आईएसएसएन: 2278-0238

फार्मेसी और जीवन विज्ञान में अनुसंधान और विकास के अंतर्राष्ट्रीय जर्नल

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

में अनुक्रमित
  • RefSeek
  • हमदर्द विश्वविद्यालय
  • ईबीएससीओ एज़
  • पबलोन्स
  • आईसीएमजेई
इस पृष्ठ को साझा करें

अमूर्त

ANTIDYSRHYTHMIC EFFECTS OF GALLIC ACID ON CaCl2-INDUCED ARRHYTHMIA IN RAT

Mahin Dianat, Ghidafeh Akbari, Mohammad Badavi

In many cases, myocardial infarction leads to arrhythmia. Since antioxidant agents play an important protective role in heart disease, therefore, many of them are used as medicinal plants in traditional medicine. Gallic acid, as a potent antioxidant agent, was shown many preventive effects on diseases; therefore, the aim of this study was the evaluation of antidysrhythmic effects of gallic acid on CaCl2-induced arrhythmia in rat. Forty male Sprague-dawley rats (200-250 gr) were divided into 5 groups included: control (N/S, 1ml/kg, gavage, 10 days), GA (10, 30, 50 mg/kg, gavage, for 10 days), quinidine (50mg/kg, iv). In all chronic groups before experiments and 10 days later, lead II electrocardiogram was recorded for calculating HR. The arrhythmia was produced by i.v. injection of a solution CaCl2 (140 mg/kg) at time effect peak chemical antiarrhythmias drugs. Then percentage of Ventricular premature beats (VPB), Ventricular fibrillation (VF) and Ventricular tachycardia (V.tach) were recorded. Results were analyzed by using t-test, one-way ANOVA and FISHER exact test. P<0.05 was considered as significant level. The chronotropic effect was not significant with GA after 10 days. GA displayed antidysrhythmic effects on CaCl2-induced arrhythmia with the highest activity at the medium dose of 50 mg/kg, compared to Control group by significant reduction of VPB, VF and V.tach comparable to that of quinidine as a chemical anti arrhythmias drug. GA considered as an antiarrhythmic agent because of reduces the incidence of VPB, Vtac and VF. Results suggest a protective role of GA against heart disease.